Skip to main content
. 2015 Oct;67(4):754–819. doi: 10.1124/pr.114.010454

Fig. 4.

Fig. 4.

(A) Three-dimensional structural details of ARBs in clinical use; and (B) interaction with human AT1 receptor. Differences in the efficacy of different ARBs may be due to small differences in interaction of shown ARBs with residues such as Tyr92, Trp182, Lys199, Met284, and P285.